These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21116799)

  • 21. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
    Vercauteren J; Vandamme AM
    Antiviral Res; 2006 Sep; 71(2-3):335-42. PubMed ID: 16782210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of antiretroviral drug resistance in antiretroviral-naive individuals.
    James CW; Moffett LE; Szabo S
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):193-5. PubMed ID: 19414829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypic antiretroviral drug resistance testing at low viral loads in the UK.
    Cane PA; Kaye S; Smit E; Tilston P; Kirk S; Shepherd J; Hopkins M; Zhang H; Geretti AM
    HIV Med; 2008 Oct; 9(8):673-6. PubMed ID: 18557948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.
    Somi GR; Kibuka T; Diallo K; Tuhuma T; Bennett DE; Yang C; Kagoma C; Lyamuya EF; Swai RO; Kassim S
    Antivir Ther; 2008; 13 Suppl 2():77-82. PubMed ID: 18575194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.
    Bertagnolio S; Parkin NT; Jordan M; Brooks J; García-Lerma JG
    AIDS Rev; 2010; 12(4):195-208. PubMed ID: 21179184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV drug resistance transmission threshold survey in Bangkok, Thailand.
    Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K
    Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug resistance in antiretroviral therapy of HIV infection].
    Oette M; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The benefits of HIV resistance testing in optimizing drug discovery.
    Heilek-Snyder G; Bean P
    Am Clin Lab; 2002 Oct; 21(8):13-4. PubMed ID: 12440169
    [No Abstract]   [Full Text] [Related]  

  • 31. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
    Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy.
    Ormaasen V; Sandvik L; Asjø B; Holberg-Petersen M; Gaarder PI; Bruun JN
    HIV Med; 2004 Nov; 5(6):400-6. PubMed ID: 15544691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 drug resistance in variants from the female genital tract and plasma.
    Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
    J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of the human immunodeficiency virus featuring laboratory testing for drug resistance.
    Scosyrev E
    Clin Lab Sci; 2006; 19(4):231-45; quiz 246-9. PubMed ID: 17181129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial comment: resistance testing--an integral part of HIV management.
    Katzenstein DA
    AIDS Read; 2003 Jan; 13(1):36. PubMed ID: 12569893
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV drug resistance and you. Resistance overview. A look at the basics.
    Munk B
    Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502
    [No Abstract]   [Full Text] [Related]  

  • 39. Modifications and substitutions of the RNA extraction module in the ViroSeq HIV-1 genotyping system version 2: effects on sensitivity and complexity of the assay.
    Stürmer M; Berger A; Doerr HW
    J Med Virol; 2003 Dec; 71(4):475-9. PubMed ID: 14556257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.
    Charpentier C; Laureillard D; Piketty C; Tisserand P; Batisse D; Karmochkine M; Si-Mohamed A; Weiss L
    AIDS; 2010 Mar; 24(6):867-73. PubMed ID: 20160635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.